Cargando…

Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study

BACKGROUND: Patients undergoing hemodialysis (HD) tend to experience hearing loss, including idiopathic sudden sensorineural hearing loss (ISSHL). However, little is known about the relationship between HD and ISSHL. OBJECTIVE: To investigate the effects of HD on the hearing level and the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kengo, Kurioka, Takaomi, Furuki, Shogo, Sano, Hajime, Ohashi, Kentaro, Ohki, Motofumi, Yamashita, Taku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513427/
https://www.ncbi.nlm.nih.gov/pubmed/34667854
http://dx.doi.org/10.1002/lio2.630
_version_ 1784583210117627904
author Yamamoto, Kengo
Kurioka, Takaomi
Furuki, Shogo
Sano, Hajime
Ohashi, Kentaro
Ohki, Motofumi
Yamashita, Taku
author_facet Yamamoto, Kengo
Kurioka, Takaomi
Furuki, Shogo
Sano, Hajime
Ohashi, Kentaro
Ohki, Motofumi
Yamashita, Taku
author_sort Yamamoto, Kengo
collection PubMed
description BACKGROUND: Patients undergoing hemodialysis (HD) tend to experience hearing loss, including idiopathic sudden sensorineural hearing loss (ISSHL). However, little is known about the relationship between HD and ISSHL. OBJECTIVE: To investigate the effects of HD on the hearing level and the treatment prognosis of ISSHL. METHODS: We reviewed the medical records of 23 patients with ISSHL receiving HD treatment (HD group) and 101 patients with ISSHL not receiving HD treatment (non‐HD group), and assessed clinical features, results of audiometric tests and blood examination results. RESULTS: Statistically significant differences were not observed in pretreatment hearing level and hearing recovery of the ear affected with ISSHL between the two groups (P > .05). Conversely, hearing thresholds in the unaffected ear were statistically different (P < .0001), and the hearing thresholds of the HD groups were significantly increased compared with those of the non‐HD groups, especially at high frequency. In addition, patients with renal dysfunction not receiving HD treatment showed similar hearing thresholds in the unaffected ear when compared with patients receiving HD treatment. CONCLUSION: HD itself did not influence the treatment prognosis of ISSHL. Renal dysfunction itself, and not HD treatment, worsened the hearing level. As similar treatment results are expected, standard treatment should be administered to patients undergoing HD. LEVEL OF EVIDENCE: 3b.
format Online
Article
Text
id pubmed-8513427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85134272021-10-18 Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study Yamamoto, Kengo Kurioka, Takaomi Furuki, Shogo Sano, Hajime Ohashi, Kentaro Ohki, Motofumi Yamashita, Taku Laryngoscope Investig Otolaryngol Otology, Neurotology, and Neuroscience BACKGROUND: Patients undergoing hemodialysis (HD) tend to experience hearing loss, including idiopathic sudden sensorineural hearing loss (ISSHL). However, little is known about the relationship between HD and ISSHL. OBJECTIVE: To investigate the effects of HD on the hearing level and the treatment prognosis of ISSHL. METHODS: We reviewed the medical records of 23 patients with ISSHL receiving HD treatment (HD group) and 101 patients with ISSHL not receiving HD treatment (non‐HD group), and assessed clinical features, results of audiometric tests and blood examination results. RESULTS: Statistically significant differences were not observed in pretreatment hearing level and hearing recovery of the ear affected with ISSHL between the two groups (P > .05). Conversely, hearing thresholds in the unaffected ear were statistically different (P < .0001), and the hearing thresholds of the HD groups were significantly increased compared with those of the non‐HD groups, especially at high frequency. In addition, patients with renal dysfunction not receiving HD treatment showed similar hearing thresholds in the unaffected ear when compared with patients receiving HD treatment. CONCLUSION: HD itself did not influence the treatment prognosis of ISSHL. Renal dysfunction itself, and not HD treatment, worsened the hearing level. As similar treatment results are expected, standard treatment should be administered to patients undergoing HD. LEVEL OF EVIDENCE: 3b. John Wiley & Sons, Inc. 2021-08-06 /pmc/articles/PMC8513427/ /pubmed/34667854 http://dx.doi.org/10.1002/lio2.630 Text en © 2021 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC. on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Otology, Neurotology, and Neuroscience
Yamamoto, Kengo
Kurioka, Takaomi
Furuki, Shogo
Sano, Hajime
Ohashi, Kentaro
Ohki, Motofumi
Yamashita, Taku
Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title_full Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title_fullStr Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title_full_unstemmed Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title_short Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study
title_sort clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: a retrospective study
topic Otology, Neurotology, and Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513427/
https://www.ncbi.nlm.nih.gov/pubmed/34667854
http://dx.doi.org/10.1002/lio2.630
work_keys_str_mv AT yamamotokengo clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT kuriokatakaomi clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT furukishogo clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT sanohajime clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT ohashikentaro clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT ohkimotofumi clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy
AT yamashitataku clinicalfeaturesandhearingprognosisofidiopathicsuddensensorineuralhearinglossinpatientsundergoinghemodialysisaretrospectivestudy